The Society of Ambulatory Anesthesia has released a consensus statement on perioperative glycemic control in diabetic patients undergoing ambulatory surgery, according to a SAMBA news release.
A panel of experts conducted a systematic review of literature on the topic and discovered that literature on perioperative glycemic control in patients undergoing ambulatory surgery is sparse and of limited quality. Recommendations were then based on general principles of blood glucose control in diabetics, drug pharmacology, data from inpatient surgical populations and clinical judgment.
The report included information on necessary preoperative information, management of preoperative oral antidiabetic and non-insulin injectable therapy, preoperative blood glucose level requirements and blood glucose level monitoring recommendations.
Read the SAMBA report on perioperative glycemic control of diabetic patients.
Read more on anesthesia:
-Anesthesiologists Should Institute Multiple Checks for Dealing With Difficult Intubation
-Blocking Receptor Might Help Control Post-Surgery Pain and Inflammation
-FDA Accepts Drug Application for Postsurgical Pain Management
A panel of experts conducted a systematic review of literature on the topic and discovered that literature on perioperative glycemic control in patients undergoing ambulatory surgery is sparse and of limited quality. Recommendations were then based on general principles of blood glucose control in diabetics, drug pharmacology, data from inpatient surgical populations and clinical judgment.
The report included information on necessary preoperative information, management of preoperative oral antidiabetic and non-insulin injectable therapy, preoperative blood glucose level requirements and blood glucose level monitoring recommendations.
Read the SAMBA report on perioperative glycemic control of diabetic patients.
Read more on anesthesia:
-Anesthesiologists Should Institute Multiple Checks for Dealing With Difficult Intubation
-Blocking Receptor Might Help Control Post-Surgery Pain and Inflammation
-FDA Accepts Drug Application for Postsurgical Pain Management